Pharmacists in Elburn, IL Accepting Medicare
10 Pharmacists found. Showing 1 - 10
 Mr. William Paul Barron, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 Fax: 630-365-4032 |
Joseph David Jaszczak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 Fax: 630-365-4032 |
Jaymin A Patel, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 |
 Dr. Samantha Rose Tasic, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 |
Mr. Mark Louis Burger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1440 Melbourne St, Elburn, IL 60119 Phone: 630-715-6258 |
John A Donnici Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 |
Dr. Jaelyn B Cook, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 |
Michael Billett Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 |
Amanda Durbin, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 Fax: 630-365-4032 |
Andrea Rauch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Main St, Elburn, IL 60119 Phone: 630-365-9176 Fax: 630-365-4032 |
News Archive
NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease
NOXXON Pharma today announced the treatment of the first patients in a Phase IIa clinical trial of its anti-hepcidin Spiegelmer NOX-H94 to treat anemia associated with chronic disease.
MMP-10 gene plays a dual role in lung cancer
A single gene that promotes initial development of the most common form of lung cancer and its lethal metastases has been identified by researchers at Mayo Clinic in Florida.
Osaka University researchers find way for early detection of AD
Kichitaro Nakajima, a graduate student at the Graduate School of Engineering Science, Hirotsugu Ogi, Associate Professor at the Graduate School of Engineering Science, and Yuji Goto, Professor at Institute for Protein Research, Osaka University succeeded in increasing the velocity constant for a reaction in which proteins causing Alzheimer disease (AD) turn into toxic substances to 1,000 times by using optimum frequency of ultrasonic irradiation.
PET scan distinguishes Alzheimer's from other dementia
A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for Alzheimer's disease, a study led by a University of Utah dementia expert has found.
› Verified 2 days ago
Pharmacists
Counselors
Dentists
Occupational Therapists
Clinical Social Workers
Marriage Counselors
Psychologists